The critical importance of retention in HIV prevention
Authors:
- 1 September 2018
- journal article
- editorial
- Published by Elsevier in The Lancet HIV
- Vol. 5 (9) , e475-e476
Abstract
No abstract availableFunding Information
- Rockefeller University
- National Institutes of Health
- National Center for Advancing Translational Sciences
This publication has 8 references indexed in Scilit:
- Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling studyThe Lancet HIV, 2018
- Preexposure Prophylaxis Initiation and Retention in Care Over 5 Years, 2012–2017: Are Quarterly Visits Too Much?Clinical Infectious Diseases, 2018
- HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short reportAIDS Care, 2016
- Retention in care outcomes for HIV pre‐exposure prophylaxis implementation programmes among men who have sex with men in three US citiesJournal of the International AIDS Society, 2016
- Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health ServicesJAMA Internal Medicine, 2016
- Planning ahead for implementation of long-acting HIV preventionCurrent Opinion in HIV and AIDS, 2015
- From Efficacy to Effectiveness: Facilitators and Barriers to PrEP Acceptability and Motivations for Adherence Among MSM and Transgender Women in New York CityAIDS Patient Care and STDs, 2013
- Variations in the Care of HIV-Infected Adults in the United StatesJAMA, 1999